These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1805491)

  • 1. Successful treatment of hemosiderosis with regular phlebotomy and recombinant human erythropoietin. Case report and ferrokinetic studies.
    Hotta T; Inoue C; Tsushita K; Miura Y; Saito H
    Acta Haematol; 1991; 86(4):214-6. PubMed ID: 1805491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
    Lazarus JM; Hakim RM; Newell J
    Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy.
    Bilgrami S; Bartolomeo A; Synnott V; Rickles FR
    Acta Haematol; 1993; 89(3):141-3. PubMed ID: 8362602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant erythropoietin and phlebotomy in the treatment of iron overload in uremic patients.
    Chen KS; Leu ML; Huang CC
    Changgeng Yi Xue Za Zhi; 1995 Sep; 18(3):248-53. PubMed ID: 8521335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment using iron depletion phlebotomy combined with recombinant erythropoietin after allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by secondary hemochromatosis].
    Shinjo K; Takeshita A; Naito K; Ohnishi K; Hirabayashi N; Ohno R
    Rinsho Ketsueki; 2001 Jul; 42(7):571-4. PubMed ID: 11524849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy.
    Chan PC; Liu P; Cronin C; Heathcote J; Uldall R
    Am J Kidney Dis; 1992 May; 19(5):484-9. PubMed ID: 1585939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: confirmation by follow-up liver biopsy.
    Onoyama K; Nakamura S; Yamamoto M; Kawadoko T; Nanishi F; Komoda T; Murai K; Fujishima M
    Nephron; 1990; 56(3):325-8. PubMed ID: 2077417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin treatment in haemodialysis patients with iron overload.
    el-Reshaid K; Johny KV; Hakim A; Kamel H; Sebeta A; Hourani H; Kanyike FB
    Acta Haematol; 1994; 91(3):130-5. PubMed ID: 8091934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of iron overload with combination of recombinant human erythropoietin and phlebotomy].
    Nagafuji K; Shibuya T; Yanagida K; Okamura T; Nakamura M; Harada M; Niho Y; Yamano Y
    Rinsho Ketsueki; 1991 Jul; 32(7):791-5. PubMed ID: 1920844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure.
    Hotta T; Ogawa H; Saito A; Ito A
    Int J Hematol; 1991 Jun; 54(3):195-200. PubMed ID: 1747454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy.
    McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP
    J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin.
    Nomura S; Osawa G; Karai M
    Nephron; 1990; 55(2):210-3. PubMed ID: 2362636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of pancreatic beta-cell function in hemochromatosis: combined treatment with recombinant human erythropoietin and phlebotomy.
    Inoue Y; Nakanishi K; Hiraga T; Okubo M; Murase T; Kosaka K; Miyakoshi S; Mutoh Y; Kobayashi T
    Am J Med Sci; 1997 Dec; 314(6):401-2. PubMed ID: 9413346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
    Matsui H; Shiraishi N; Yasuda T; Nezuka T
    Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: a pilot, open-label study with neurophysiological measurements.
    Créange A; Lefaucheur JP; Balleyguier MO; Galactéros F
    Neurophysiol Clin; 2013 Dec; 43(5-6):303-12. PubMed ID: 24314757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine abnormalities in hemodialysis patients with iron overload: reversal with iron depletion.
    el-Reshaid K; Seshadri MS; Hourani H; Qurtom M; Kamel H
    Nutrition; 1995; 11(5 Suppl):521-6. PubMed ID: 8748213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.